Takeaways
- Congress has delayed many of the new federal restrictions on hemp-derived THC products from November 12 to December 11, 2026, following enactment of H.R. 6500.
- The delay does not appear to apply uniformly, meaning some cannabinoid products could face changes in federal treatment beginning November 12, 2026.
- The new definition also targets hemp-derived cannabinoid products involving cannabinoids synthesized or manufactured outside the cannabis plant, potentially affecting many products currently sold nationwide.
Last week, as part of a continuing resolution to extend the federal budget until after the election, Congress voted to delay implementation of substantial changes concerning hemp until December 11, 2026. The “CR” was promptly signed into law by President Trump.
The CR does not make any substantive changes to the budget bill that ended the federal government shutdown last fall, and that included provisions to dramatically alter provisions of the 2018 Farm Bill surrounding intoxicating hemp-derived cannabinoid products. In an answer to the proliferation of intoxicating hemp-derived products that have flooded the market, Congress made significant changes to the definition of hemp:
Continue Reading Federal Intoxicating Hemp Ban Changes Pushed Back Until December 11, 2026

